Skip to main content
SpringerLink
Log in

Treatment of Refractory Myofascial Pain of the Neck and Shoulder Girdle with Botulinum Toxin A

  • Chapter
  • First Online:
Minimally Invasive Spine Intervention

  • 363 Accesses

Abstract

Therapy-refractory myofascial pain in the neck and shoulder girdle represents a not inconsiderable proportion of orthopaedic, accident surgery and neurological patients. In addition to oral/parenteral drug therapy, physical therapy, physiotherapy, manual medicine as well as needle procedures (acupuncture, dry needling) and shock wave therapy, infiltrative procedures play a major role in the treatment options, if necessary also supplemented by psychopharmacological and psychotherapeutic treatments. A number of substances are used in infiltrative procedures: Homeopathics, NaCl, various local anesthetics (sometimes in combination with corticosteroids), botulinum toxin. In this article, in addition to a general introduction to the modes of action and indications for botulinum toxin, this treatment will be presented and discussed on the basis of the literature, combined with a practice-oriented flow chart and classification in an overall therapy concept.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bullinger M, Kirchberger I (1998) SF-36-Fragebogen zum Gesundheitszustand (PSYNDEX Tests Review). https://www.zpid.de/retrieval/PSYNDEXTests.php?id=9003482. Accessed on 30.07.2018

    Google Scholar 

  • Bundesamt für Bevölkerungsschutz und Katastrophenhilfe (2007) Biologische Gefahren II, Entscheidungshilfen zu medizinisch angemessenen Vorgehensweisen in einer B-Gefahrenlage. Bonn, S 204–216. http://www.bbk.bund.de/SharedDocs/Downloads/BBK/DE/Publikationen/PublikationenForschung/BioGefahren-II-MedVers.pdf?__blob=publicationFile. Accessed on 30.07.2018

  • Ferrante F, Bearn L, Rothrock R, King L (2005) Evidence against trigger point injection technique for the treatment of cervicothoracic myofascial pain with botulinum toxin type a. Anesthesiology 103:377–383

    Article  CAS  PubMed  Google Scholar 

  • Freund B, Schwartz M (2000) Treatment of chronic cervical-associated headache with botulinum toxin type a: a pilot study. Headache 40:231–236

    Article  CAS  PubMed  Google Scholar 

  • Göbel H, Heinze A, Reichel G, Hefter H, Benecke R et al (2006) Efficacy and safety of a single botulinum type a toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome. Pain 125:82–88

    Article  PubMed  Google Scholar 

  • Graboski C, Gray D, Burnham R (2005) Botulinum toxin a versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome. Pain 118:170–175

    Article  CAS  PubMed  Google Scholar 

  • Halb L, Amann B, Bornemann-Cimenti H (2017) Einsatz intra- bzw. subkutaner Botulinumtoxine bei Post-Zoster-Neuralgie. Nervenarzt 88:408–414

    Article  CAS  PubMed  Google Scholar 

  • Hamilton M (1959) The assessment on anxiety states by rating. Br J Med Psychol 32:50–55

    Article  CAS  PubMed  Google Scholar 

  • Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Holle D, Rabe K, Obermann M, Straube A, Gerwig M, Diener C (2012) Botulinumtoxin bei Kopfschmerzen. Akt Neurol 39:546–552

    Google Scholar 

  • Hong B, Chang H, Lee S, Park J, Kwon J (2017) Efficacy of repeated botulinum toxin type a injections for spastic equinus in children with cerebral palsy-a secondary analysis of the randomized clinical trial. Toxins 9(8):253

    Article  PubMed  PubMed Central  Google Scholar 

  • Hunt S, Mc Kenna S, Mc Ewen J, Backett E, Williams J, Papp E (1980) A quantitative approach to perceived health status: a validation study. J Epidemiol Community Health 34:281–286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jackson-Koku G (2016) Beck depression inventory. Occup Med 66:174–175

    Article  Google Scholar 

  • Jerosch J, Söhling M et al (2012) Open-label, multicenter, randomized study investigating the efficacy and safety of botulinum toxin type a in the treatment of myofascial pain syndrome in the neck and shoulder girdle. J Musculoskelet Pain 2:95–99

    Article  Google Scholar 

  • Jorritsma W, de Vries G, Dijkstra P, Geertzen J, Reneman M (2012) Neck pain and disability scale and neck disability index: validity of Dutch language versions. Eur Spine J 12(1):93–100

    Article  Google Scholar 

  • Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Ozkurt Zengin F, Bayik A (2003) Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 25:604–611

    Article  Google Scholar 

  • Kwanchuay P, Petchnumsin T, Yiemsiri P, Pasuk N, Srikanok W, Hathaiareerug C (2015) Efficacy and safety of single botulinum toxin type a (Botox®) injection for relief of upper trapeziusMyofascial trigger point: a randomized, double-blind, placebo-controlled study. J Med Assoc Thail 98(12):1231–1236

    Google Scholar 

  • Ojala T, Arokoski J, Partanen J (2006) The effect of small doses of botulinumtoxin toxin a on neck-shoulder myofascial pain syndrome. Clin J Pain 22(1):90–96

    Article  PubMed  Google Scholar 

  • Placzek R (Hrsg) (2006) Botulinumtoxin in Orthopädie und Sportmedizin—Evaluation eines neuen Wirkstoffes zur klinischen Anwendung im Fachgebiet Orthopädie. Habilitationsschrift, Medizinische Fakultät der Charité, Universitätsmedizin Berlin

    Google Scholar 

  • Schelosky L (2016a) Klinische Anwendung von Botulinumtoxin Typ A. In: Sommer B, Bergfeld D, Sattler G (Hrsg) Botulinumtoxin in der ästhetischen Medizin. Thieme, Stuttgart, S 10–11

    Google Scholar 

  • Schelosky L (2016b) Pharmakologie des Botulinumtoxins. In: Sommer B, Bergfeld D, Sattler G (Hrsg) Botulinumtoxin in der ästhetischen Medizin. Thieme, Stuttgart, S 18–22

    Google Scholar 

  • Schulz A, Grüner S, Lippert-Grüner M (2016) Botulinumtoxin – mögliche Indikationen in O & U. OUP 4:218–221

    Google Scholar 

  • Simons D, Travell J, Simons L (1998) Myofascial pain and dysfunction: the trigger point manual volume I upper half of body. Lippincott Williams Wilkins, Philadelphia

    Google Scholar 

  • Sommer B, Bergfeld D (2016) Präparate und Dosierungen. In: Sommer B, Bergfeld D, Sattler G (Hrsg) Botulinumtoxin in der ästhetischen Medizin. Thieme, Stuttgart, S 23–25

    Google Scholar 

  • Wheeler A, Goolkasian P, Gretz S (1998) A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cercicothoracic, paraspinal, myofascial pain syndrome. Spine 23(15):1662–1667

    Article  CAS  PubMed  Google Scholar 

  • Wheeler AH, Goolkasian P, Baird AC, Darden B (1999) Development of the neck pain and disability scale. Spine 24(13):1290–1294

    Article  CAS  PubMed  Google Scholar 

  • Wheeler A, Goolkasian P, Gretz S (2001) Botulinum toxin a for the treatment of chronic neck pain. Pain 94:255–260

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Private Institute, Cologne, Germany

    S. Grüner

  2. Klinik für Rehabilitative Medizin, Fakultätskrankenhaus Královské Vinohrady, Medizinische Fakultät Karlsuniversität Prag, Praha, Czech Republic

    M. Lippert-Grüner

  3. Privatpraxis für Orthopädie, Lüdenscheid, Germany

    A. Schulz

Authors
  1. S. Grüner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Lippert-Grüner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Grüner .

Editor information

Editors and Affiliations

  1. Meerbusch, Germany

    Jörg Jerosch

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer-Verlag GmbH Germany, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Grüner, S., Lippert-Grüner, M., Schulz, A. (2023). Treatment of Refractory Myofascial Pain of the Neck and Shoulder Girdle with Botulinum Toxin A. In: Jerosch, J. (eds) Minimally Invasive Spine Intervention. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63814-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-63814-9_6

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-63813-2

  • Online ISBN: 978-3-662-63814-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation